Skip to main content
. 2019 Nov 30;8(1):34–40. doi: 10.1016/j.prnil.2019.10.004

Table 3.

Percentage relapse at 2 and 5 years after treatment.

% Relapse Control (n = 58) Celecoxib (n- = 60) Meloxicam (n = 53) P value
Relapse at 2 years 8.6% (n = 5) 6.7% (n = 4) 0.0% (n = 0) 0.730
Relapse at 5 years 31.0% (n = 19) 18.3% (n = 11) 18.9% (n = 10) 0.145